Document is current

Any future updates will be listed below

A Cost-effectiveness Analysis of Adding Cetuximab to the First-line Treatment of Metastatic Colorectal Carcinoma in Iran; Considering Genetic Screening for Precision Medicine

Crossref DOI link: https://doi.org/10.1007/s12029-022-00904-1

Published Online: 2023-01-09

Published Print: 2023-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark